City Island, NY, United States of America

John S Condeelis

This inventor holds 16 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Albert Einstein College of Medicine, Massachusetts Institute of Technology, Ifo-Regina Elena Cancer Institute. Active years: 2012-2025.

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

City Island, NY (US) (2012)
Bronx, NY (US) (2013 - 2024)

Company Filing History:

16 out of 513

Albert Einstein College of Medicine

patents

6 out of 8,578

Massachusetts Institute of Technology

patents

2 out of 2

Ifo-Regina Elena Cancer Institute

King's College London

patents

6. 1 out of 64

Montefiore Medical Center

patents

7. 1 out of 2,044

The State University of New York

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12298308 - Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism (2025-05-13),

2. 12174190 - Combined markers for metastatic cancer and uses thereof (2024-12-24),

3. 12089959 - High resolution intravital imaging and uses thereof (2024-09-17),

4. 12055547 - TMEM active test and uses thereof in diagnosis, prognosis and treatment of tumors (2024-08-06),

5. 11802875 - Method for treating neoadjuvant chemotherapy-induced metastasis (2023-10-31),

6. 11712205 - High resolution intravital imaging and uses thereof (2023-08-01),

7. 11169154 - Phosphocofilin: cofilin co-localization intensity as a predictor of metastatic recurrence (2021-11-09),

8. 10928397 - Methods involving Menain screening for inhibitors of cancer invasion and metastasis (2021-02-23),

9. 10117990 - Microfluidic intravital window (2018-11-06),

10. 10114023 - [object Object] (2018-10-30),

11. 9970057 - Human invasion signature for prognosis of metastatic risk (2018-05-15),

12. 9926601 - Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer (2018-03-27),

13. 9719142 - Metastasis specific splice variants of Mena and uses thereof in diagnosis, prognosis and treatment of tumors (2017-08-01),

14. 8642277 - Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors (2014-02-04),

15. 8603738 - Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors (2013-12-10),

Title: The Innovative Contributions of John S. Condeelis

Introduction

John S. Condeelis is a prominent inventor based in City Island, NY (US). He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms of metastasis and developing methods to combat chemotherapy-induced cancer cell dissemination. With a total of 16 patents to his name, Condeelis has established himself as a leading figure in his area of expertise.

Latest Patents

Among his latest patents, Condeelis has developed methods for reducing chemotherapy-induced metastasis through a TMEM-mediated mechanism. These methods utilize Tie-2 inhibitors to help patients undergoing chemotherapy. Additionally, he has created techniques to reduce cancer cell dissemination using inhibitors of Mena expression and/or function. Another notable patent involves a combination of markers for hematogenous metastatic cancer, including TMEM, MenaCalc, and MenalNV, which are used for diagnosis, prognosis, and predictive performance.

Career Highlights

Condeelis has had a distinguished career, working at esteemed institutions such as Albert Einstein College of Medicine and the Massachusetts Institute of Technology. His research has significantly advanced the understanding of cancer biology and has the potential to improve treatment outcomes for patients.

Collaborations

Throughout his career, Condeelis has collaborated with notable colleagues, including Frank B. Gertler and Maja H. Oktay. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

John S. Condeelis is a remarkable inventor whose work has had a profound impact on cancer research and treatment. His innovative patents and collaborations continue to pave the way for advancements in the field.